This content is only available within our institutional offering.
27 Mar 2019
LIBERUM: Morning Comment
Novartis AG (NOVN:SWX), 0 | Imperial Brands PLC (IMB:LON), 1,775 | Bellway p.l.c. (BWY:LON), 2,668 | AstraZeneca PLC (AZN:LON), 10,689 | GSK plc (GSK:LON), 1,709 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Morning Comment
Novartis AG (NOVN:SWX), 0 | Imperial Brands PLC (IMB:LON), 1,775 | Bellway p.l.c. (BWY:LON), 2,668 | AstraZeneca PLC (AZN:LON), 10,689 | GSK plc (GSK:LON), 1,709 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0
- Published:
27 Mar 2019 -
Author:
Liberum Research Team -
Pages:
5